Acumen Pharmaceuticals ABOS is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Acumen Pharmaceuticals to report an earnings per share (EPS) of $-0.36.
The announcement from Acumen Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings History Snapshot
In the previous earnings release, the company missed EPS by $0.06, leading to a 9.21% drop in the share price the following trading session.
Here's a look at Acumen Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.26 | -0.26 | -0.27 |
| EPS Actual | -0.34 | -0.25 | -0.29 | -0.24 |
| Price Change % | -9.0% | 3.0% | 9.0% | 5.0% |
Tracking Acumen Pharmaceuticals's Stock Performance
Shares of Acumen Pharmaceuticals were trading at $3.27 as of November 08. Over the last 52-week period, shares are up 51.64%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Acumen Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
